0001437749-22-004668.txt : 20220228 0001437749-22-004668.hdr.sgml : 20220228 20220228171557 ACCESSION NUMBER: 0001437749-22-004668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220224 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guse Kyle CENTRAL INDEX KEY: 0001566618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 22691418 MAIL ADDRESS: STREET 1: C/O ATOSSA GENETICS INC. STREET 2: 1616 EASTLAKE AVE. E SUITE 510 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4 1 rdgdoc.xml FORM 4 X0306 4 2022-02-24 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001566618 Guse Kyle C/O ATOSSA THERAPEUTICS, INC. 107 SPRING STREET SEATTLE WA 98104 1 CFO, Gen Counsel and Secretary Stock Option (right to buy) 1.25 2022-02-24 4 A 0 746667 0 A 2032-02-24 Common Stock 746667 746667 D The options will vest on a quarterly basis over two (2) years. /s/ Kyle Guse 2022-02-28